An excerpt of an international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease(2023)
In 2020,an international expert panel proposed to replace nonalcoholic fatty liver disease with metabolic associated fatty liver disease(MAFLD).Recent studies have shown that there is a higher risk of chronic kidney disease(CKD)in the MAFLD population and that MAFLD is an independent risk factor for CKD.However,up to now,there are still no guidelines on the prevention and treatment of MAFLD-related CKD.Based on the Delphi method,the authors led a multidisciplinary team of 50 authoritative experts from 26 countries to reach a consensus on some open-ended research issues about the association between MAFLD and CKD,which can help to clarify the important clinical association between MAFLD and the risk of CKD and improve the understanding of the epidemiology,pathogenesis,management,and treatment of MAFLD and CKD,so as to establish a framework for the early prevention and management of these two common and interrelated diseases.
国家科技期刊平台
NSTL
万方数据
维普
